AKT1 and ovarian cancer: Our observation is in agreement with Xia et al (2006) who demonstrated, by using siRNA against AKT, the downregulation of VEGF expression in ovarian cancer cells, and the inhibition of angiogenesis in CAM chick embryo assay.